This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genentech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seyed Mohammadmohsen Hejrati: Innovator in Biomarker Identification
Introduction
Seyed Mohammadmohsen Hejrati is a notable inventor based in Stanford, CA. He has made significant contributions to the field of biomarker identification and discovery. His innovative work focuses on determining the health status of the retina using advanced imaging techniques.
Latest Patents
Hejrati holds a patent for "Methods and systems for biomarker identification and discovery." This patent describes systems and methods for assessing the health status of a subject's retina. The process involves receiving an optical coherence tomography (OCT) volume image of the retina. A health indication output is generated through a deep learning model, which utilizes the OCT volume image. This output indicates the level of association between the OCT image and a selected health status category for the retina. Additionally, a map output for the deep learning model is created using a saliency mapping algorithm, which highlights the contribution of specific regions in the OCT volume image to the health indication output.
Career Highlights
Hejrati is currently employed at Genentech, Inc., where he continues to advance his research in biomarker identification. His work has the potential to significantly impact the field of ophthalmology and improve patient outcomes.
Collaborations
He has collaborated with notable colleagues, including Heming Yao and Miao Zhang, who contribute to his research efforts.
Conclusion
Seyed Mohammadmohsen Hejrati is a pioneering inventor whose work in biomarker identification is paving the way for advancements in retinal health assessment. His contributions are essential in the ongoing development of innovative medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
